Celtaxsys' Series C Round

Celtaxsys raised a round of funding on May 22, 2009. Investors include Caymus Partners.

Celtaxsys is a clinical-stage pharmaceutical development company focused on advancing novel foundational therapies to treat inflammation in rare, orphan designated diseases. The company's flagship inv…

Articles about Celtaxsys' Series C Round: